2Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.The protein kinase complement of the human genome. Science 2002; 298: 1912-34.
3Bottaro DP, Rubin JS, Faletto DL, Chart AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251 : 802-4.
4Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P. MET(PRC) mutations in the RON receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential. J Cell Physiol 1999; 181: 507-14.
5Chen YQ, Zhou YQ, Fu LH, Wang D, Wang MH. Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Carcinogenesis 2002; 23:1811-9.
6Zhou YQ, Chen YQ, Fisher JH, Wang MH. Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogene 2002; 21: 6382-6.
7Barkley JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol 1996; 14: 2377-86.
8Thiery JP, Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 1999; 18: 31-42.
9Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001; 23: 912-23.
10Wang D, Shen Q, Chen YQ, Wang MH. Collaborative activities of macrophage-stimulating protein and transforming growth factor-betal in induction of epithelial to mesenchymal transition:roles of the RON receptor tyrosine kinase. Oncogene 2004; 23:1668-80.
